Paydirt
RE
Insider

Robert S Epstein

Director · Veracyte

Robert S Epstein (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Veracyte, Inc. (VCYT). The largest single filing was $440K of VCYT (10,000 sh × $44.01, as filed), executed May 20. Data as of Nov 8 2026.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$440K
shares × price, as filed
Last traded
May 20
Filed May 22

Median ADV $55.3M across their filed names

Open performance→
Volume by month
$753K$377K$0Dec 2024Jun 2025Dec 2025Jun 2026Oct 2025 · sells $753KMay 2026 · sells $440K
Buys $0 Sells $1.2M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 1 filing

Sector per market data · by filing · past 12 months

Most traded names
VCYT Veracyte, Inc. VCYT · 0 buys · 3 sells 3 filings
Recent filings
VCYTSALE Veracyte, Inc. View filing → $440K
10,000 sh × $44.01
Exec May 20
Filed May 22 · 5:30 PM ET VCYTSALE Veracyte, Inc. View filing → $753K
21,473 sh × $35.08
Exec Oct 1 2025
Filed Oct 3 2025 · 5:30 PM ET VCYTSALE Veracyte, Inc. View filing → $575K
15,000 sh × $38.32
Exec Nov 12 2024
Filed Nov 14 2024 · 5:30 PM ET